The University of Newcastle, Australia

CANCER: Biomarkers and Targeted Therapy

Closing Date: 12 August 2019


PhD Scholarship

You will be involved in the discovery and development of new prognostic markers to improve prediction of tumour behaviour, host profiling to predict and prevent adverse reactions, or the development of novel biomarkers and targeted therapies. You will have the opportunity to link basic science discoveries with innovative clinical trials and studies.

cancer

The Hunter Cancer Research Alliance (HCRA) brings together leading cancer researchers and clinicians from the University of Newcastle, the Hunter Medical Research Institute, the Hunter New England Local Health District and the Calvary Mater Hospital Newcastle. HCRA provides capacity building, funding and strategic support to over 400 members. Cancer research in the Hunter spans the full translational spectrum from basic laboratory science to clinical trials and behavioural, implementation and health services research.

HCRA supports three flagship programs:

1. Biomarkers and Targeted Therapy (BTT)

2. Radiation Oncology, Cancer Imaging & Technology (ROCIT).

3. Implementation Science & Impact (ISI) HCRA is offering one (1) PhD Scholarship under the Biomarkers and Targeted Therapy (BTT) Flagship Program.

For this opportunity, the BTT Flagship Program has six (6) potential projects that the successful candidate can select from.

  1. Regulation of the response to DNA damaging therapies in breast cancer
  2. Novel biomarkers for early identification of cancer therapy-induced cardiotoxicity
  3. Analysis of therapeutic proteins for monitoring immunotherapy treatment of cancer patients
  4. Neuronal Biomarkers to identify prostate cancers
  5. Identifying the molecular mechanisms of Glioblastoma response to therapy
  6. Investigation of the immune system and the tumour microenvironment in glioblastoma

Depending on the project chosen, the respective supervisors are:

1. Dr Kelly Avery Kiejda – Regulation of the response to DNA damaging therapies in breast cancer

2. A/Prof Aaron Sverdlov – Novel biomarkers for early identification of cancer therapy-induced cardiotoxicity

3. Dr Peter Galettis – Analysis of therapeutic proteins for monitoring immunotherapy treatment of cancer patients

4. Prof Hubert Hondermarck – Neuronal Biomarkers to identify prostate cancers

5. Dr Kelly Avery Kiejda  - Identifying the molecular mechanisms of Glioblastoma response to therapy

6.  A/Prof Paul Tooney – Investigation of the immune system and the tumour microenvironment in glioblastoma

PhD Scholarship details

Funding: $27,596 per annum (2019 rate) indexed annually. For a PhD candidate, the living allowance scholarship is for 3.5 years and the tuition fee scholarship is for four years.

Supervisor: Please see the detailed description above (PhD Scholarship) for the supervisors and their respective projects

Available to: Domestic and International students

PhD

Eligibility Criteria

The applicant will need to meet the minimum eligibility criteria for admission.

Application Procedure

1. If you are interested in working on a PhD project in one of these areas, please send an email introducing yourself to HCRA-biomarkers@newcastle.edu.au
2. HCRA will send you research profiles of the potential supervisors. You will be invited to read over these profiles and make contact with the supervisors whose area of research interests you.
3. The supervisor(s) that you have contacted will meet you and assess your suitability to work as part of their team. They may then offer to work with you to prepare a HCRA PhD Application. (NB. Each supervisor has complete discretion when deciding on potential PhD students).
4. The Student (with supervisor approval) submits an application to HCRA-Biomarkers@newcastle.edu.au using the application form provided to the Supervisor.
5. Student/ Supervisor project applications will be assessed by the HCRA Joint Evaluation Committee and the strongest applicant and project combination will be awarded the scholarship.
6. If you have any questions about the PhD Scholarship or the process please contact HCRA-biomarkers@newcastle.edu.au or phone 4042 0775.

Please send the email expressing interest to HCRA-biomarkers@newcastle.edu.au by 5pm on 12 August 2019.

Applications Close 12 August 2019


Contact Sarah Nielsen
Phone 02 4042 0775
Email HCRA-biomarkers@newcastle.edu.au

PhD and Research MastersFind out more